Last 12 months
Inside the activity.
4 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Disposition to issuerCommon Stock | 42,764 | $55.89 | $2,390,079.96 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 26 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,463 F10 · kind: The reporting person received 27,098 shares of common stock upon the net exercise of 100,000 SARS. The reporting person forfeited 42,764 shares of common stock underlying the SARS in payment of the exercise price and 30,138 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Exercise / conversionCommon Stock | 100,000 | $23.90 | $2,390,000.00 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 25 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,227 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · kind: The reporting person received 27,098 shares of common stock upon the net exercise of 100,000 SARS. The reporting person forfeited 42,764 shares of common stock underlying the SARS in payment of the exercise price and 30,138 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Tax withholdingCommon Stock | 68,751 | $55.89 | $3,842,493.39 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 24 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,227 F9 · kind: The reporting person received 61,824 shares of common stock upon the net exercise of 179,444 SARS. The reporting person forfeited 48,869 shares of common stock underlying the SARS in payment of the exercise price and 68,751 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Disposition to issuerCommon Stock | 48,869 | $55.89 | $2,731,288.41 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 23 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,978 F9 · kind: The reporting person received 61,824 shares of common stock upon the net exercise of 179,444 SARS. The reporting person forfeited 48,869 shares of common stock underlying the SARS in payment of the exercise price and 68,751 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Exercise / conversionCommon Stock | 179,444 | $15.22 | $2,731,137.68 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 22 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 476,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · kind: The reporting person received 61,824 shares of common stock upon the net exercise of 179,444 SARS. The reporting person forfeited 48,869 shares of common stock underlying the SARS in payment of the exercise price and 68,751 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Tax withholdingCommon Stock | 28,175 | $55.89 | $1,574,700.75 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 21 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,403 F8 · kind: The reporting person received 25,333 shares of common stock upon the net exercise of 115,472 SARS. The reporting person forfeited 61,964 shares of common stock underlying the SARS in payment of the exercise price and 28,175 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Disposition to issuerCommon Stock | 61,964 | $55.89 | $3,463,167.96 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 20 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,578 F8 · kind: The reporting person received 25,333 shares of common stock upon the net exercise of 115,472 SARS. The reporting person forfeited 61,964 shares of common stock underlying the SARS in payment of the exercise price and 28,175 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Exercise / conversionCommon Stock | 115,472 | $29.99 | $3,463,005.28 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 19 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · kind: The reporting person received 25,333 shares of common stock upon the net exercise of 115,472 SARS. The reporting person forfeited 61,964 shares of common stock underlying the SARS in payment of the exercise price and 28,175 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Tax withholdingCommon Stock | 13,773 | $55.89 | $769,772.97 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 18 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,070 F7 · kind: The reporting person received 12,382 shares of common stock upon the net exercise of 90,798 SARS. The reporting person forfeited 64,643 shares of common stock underlying the SARS in payment of the exercise price and 13,773 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Disposition to issuerCommon Stock | 64,643 | $55.89 | $3,612,897.27 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 17 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,843 F7 · kind: The reporting person received 12,382 shares of common stock upon the net exercise of 90,798 SARS. The reporting person forfeited 64,643 shares of common stock underlying the SARS in payment of the exercise price and 13,773 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Exercise / conversionCommon Stock | 90,798 | $39.79 | $3,612,852.42 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 16 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · kind: The reporting person received 12,382 shares of common stock upon the net exercise of 90,798 SARS. The reporting person forfeited 64,643 shares of common stock underlying the SARS in payment of the exercise price and 13,773 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Tax withholdingCommon Stock | 50,154 | $55.89 | $2,803,107.06 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 15 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,688 F6 · kind: The reporting person received 45,105 shares of common stock upon the net exercise of 158,950 SARS. The reporting person forfeited 63,691 shares of common stock underlying the SARS in payment of the exercise price and 50,154 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Disposition to issuerCommon Stock | 63,691 | $55.89 | $3,559,689.99 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 14 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,842 F6 · kind: The reporting person received 45,105 shares of common stock upon the net exercise of 158,950 SARS. The reporting person forfeited 63,691 shares of common stock underlying the SARS in payment of the exercise price and 50,154 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Exercise / conversionCommon Stock | 158,950 | $22.40 | $3,560,480.00 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 13 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 373,533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · kind: The reporting person received 45,105 shares of common stock upon the net exercise of 158,950 SARS. The reporting person forfeited 63,691 shares of common stock underlying the SARS in payment of the exercise price and 50,154 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Tax withholdingCommon Stock | 22,959 | $55.89 | $1,283,178.51 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 12 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,583 F5 · kind: The reporting person received 20,646 shares of common stock upon the net exercise of 83,334 SARS. The reporting person forfeited 39,729 shares of common stock underlying the SARS in payment of the exercise price and 22,959 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Disposition to issuerCommon Stock | 39,729 | $55.89 | $2,220,453.81 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 11 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,542 F5 · kind: The reporting person received 20,646 shares of common stock upon the net exercise of 83,334 SARS. The reporting person forfeited 39,729 shares of common stock underlying the SARS in payment of the exercise price and 22,959 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Exercise / conversionCommon Stock | 83,334 | $26.65 | $2,220,851.10 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 10 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,271 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The reporting person received 20,646 shares of common stock upon the net exercise of 83,334 SARS. The reporting person forfeited 39,729 shares of common stock underlying the SARS in payment of the exercise price and 22,959 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Tax withholdingCommon Stock | 25,497 | $55.89 | $1,425,027.33 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 9 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,937 F4 · kind: The reporting person received 22,930 shares of common stock upon the net exercise of 60,932 SARS. The reporting person forfeited 12,505 shares of common stock underlying the SARS in payment of the exercise price and 25,497 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Disposition to issuerCommon Stock | 12,505 | $55.89 | $698,904.45 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 8 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,434 F4 · kind: The reporting person received 22,930 shares of common stock upon the net exercise of 60,932 SARS. The reporting person forfeited 12,505 shares of common stock underlying the SARS in payment of the exercise price and 25,497 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Exercise / conversionCommon Stock | 60,932 | $11.47 | $698,890.04 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 7 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,939 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: The reporting person received 22,930 shares of common stock upon the net exercise of 60,932 SARS. The reporting person forfeited 12,505 shares of common stock underlying the SARS in payment of the exercise price and 25,497 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Tax withholdingCommon Stock | 68,667 | $55.89 | $3,837,798.63 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 6 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,007 F3 · kind: The reporting person received 61,753 shares of common stock upon the net exercise of 160,000 SARS. The reporting person forfeited 29,580 shares of common stock underlying the SARS in payment of the exercise price and 68,667 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Disposition to issuerCommon Stock | 29,580 | $55.89 | $1,653,226.20 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 5 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,674 F3 · kind: The reporting person received 61,753 shares of common stock upon the net exercise of 160,000 SARS. The reporting person forfeited 29,580 shares of common stock underlying the SARS in payment of the exercise price and 68,667 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Exercise / conversionCommon Stock | 160,000 | $10.33 | $1,652,800.00 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 4 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The reporting person received 61,753 shares of common stock upon the net exercise of 160,000 SARS. The reporting person forfeited 29,580 shares of common stock underlying the SARS in payment of the exercise price and 68,667 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Tax withholdingCommon Stock | 49,438 | $55.89 | $2,763,089.82 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 3 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,254 F1 · kind: The reporting person received 44,460 shares of common stock upon the net exercise of 100,000 stock appreciation rights ("SARS"). The reporting person forfeited 6,102 shares of common stock underlying the SARS in payment of the exercise price and 49,438 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Disposition to issuerCommon Stock | 6,102 | $55.89 | $341,040.78 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 2 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,692 F1 · kind: The reporting person received 44,460 shares of common stock upon the net exercise of 100,000 stock appreciation rights ("SARS"). The reporting person forfeited 6,102 shares of common stock underlying the SARS in payment of the exercise price and 49,438 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Exercise / conversionCommon Stock | 100,000 | $3.41 | $341,000.00 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 1 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person received 44,460 shares of common stock upon the net exercise of 100,000 stock appreciation rights ("SARS"). The reporting person forfeited 6,102 shares of common stock underlying the SARS in payment of the exercise price and 49,438 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. F2 · balance_after: On May 14, 2018, the common stock of Herbalife Nutrition Ltd. split 2-for-1, resulting in the reporting person's acquisition of 32,397 additional shares of common stock. Read SEC document |
| August 03, 2018 Filed Aug 6, 2018 20:17 UTC |
Dunn JeffDirector
|
SaleCommon Stock | 17,440 | $58.53 | $1,020,763.20 |
DisclosureSEC source: 0001209191-18-045517 · doc4.xml · nonDerivative · entry 1 Dunn Jeff · CIK 0001476192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,076 F1 · balance_after: On May 14, 2018, the common stock of Herbalife Nutrition Ltd. split 2-for-1, resulting in the reporting person's acquisition of 33,258 additional shares of common stock. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 20:16 UTC |
Hoffman Alan LEVP, Global Corporate Affairs
|
Exercise / conversionStock Appreciation Rights · Derivative | 8,734 | $0.00 Strike: $31.26 | $0.00 |
DisclosureSEC source: 0001209191-18-045516 · doc4.xml · derivative · entry 9 Hoffman Alan L · CIK 0001624527 · EVP, Global Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,200 Underlying: Common Stock · 8,734 shares Expires 2026-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2018. F6 · kind: These SARS were previously reported as covering 21,834 shares at an exercise price of $62.51 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. F7 · derivative.exercise_date: On May 9, 2016, the reporting person was granted 43,668 (post-split) Stock Appreciation Rights (SARs). These SARs vested 20% on May 9, 2017, 20% on May 9, 2018, and the remaining 60% will vest on May 9, 2019. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 20:16 UTC |
Hoffman Alan LEVP, Global Corporate Affairs
|
Exercise / conversionStock Appreciation Rights · Derivative | 26,512 | $0.00 Strike: $15.22 | $0.00 |
DisclosureSEC source: 0001209191-18-045516 · doc4.xml · derivative · entry 8 Hoffman Alan L · CIK 0001624527 · EVP, Global Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,504 Underlying: Common Stock · 26,512 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2018. F5 · kind: These SARS were previously reported as covering 53,017 shares at an exercise price of $30.44 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 20:16 UTC |
Hoffman Alan LEVP, Global Corporate Affairs
|
Tax withholdingCommon Stock | 1,987 | $57.74 | $114,729.38 |
DisclosureSEC source: 0001209191-18-045516 · doc4.xml · nonDerivative · entry 7 Hoffman Alan L · CIK 0001624527 · EVP, Global Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,623 F4 · kind: The reporting person received 2,019 shares of common stock upon the net exercise of 8,734 SARS. The reporting person forfeited 4,728 shares of common stock underlying the SARS in payment of the exercise price and 1,987 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on August 2, 2018 of $57.74. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 20:16 UTC |
Hoffman Alan LEVP, Global Corporate Affairs
|
Disposition to issuerCommon Stock | 4,728 | $57.74 | $272,994.72 |
DisclosureSEC source: 0001209191-18-045516 · doc4.xml · nonDerivative · entry 6 Hoffman Alan L · CIK 0001624527 · EVP, Global Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,610 F4 · kind: The reporting person received 2,019 shares of common stock upon the net exercise of 8,734 SARS. The reporting person forfeited 4,728 shares of common stock underlying the SARS in payment of the exercise price and 1,987 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on August 2, 2018 of $57.74. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 20:16 UTC |
Hoffman Alan LEVP, Global Corporate Affairs
|
Exercise / conversionCommon Stock | 8,734 | $31.26 | $272,981.17 |
DisclosureSEC source: 0001209191-18-045516 · doc4.xml · nonDerivative · entry 5 Hoffman Alan L · CIK 0001624527 · EVP, Global Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,338 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: The reporting person received 2,019 shares of common stock upon the net exercise of 8,734 SARS. The reporting person forfeited 4,728 shares of common stock underlying the SARS in payment of the exercise price and 1,987 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on August 2, 2018 of $57.74. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 20:16 UTC |
Hoffman Alan LEVP, Global Corporate Affairs
|
Tax withholdingCommon Stock | 9,681 | $57.74 | $558,980.94 |
DisclosureSEC source: 0001209191-18-045516 · doc4.xml · nonDerivative · entry 4 Hoffman Alan L · CIK 0001624527 · EVP, Global Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,604 F3 · kind: The reporting person received 9,840 shares of common stock upon the net exercise of 26,512 stock appreciation rights ("SARS"). The reporting person forfeited 6,991 shares of common stock underlying the SARS in payment of the exercise price and 9,681 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on August 2, 2018 of $57.74. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 20:16 UTC |
Hoffman Alan LEVP, Global Corporate Affairs
|
Disposition to issuerCommon Stock | 6,991 | $57.74 | $403,660.34 |
DisclosureSEC source: 0001209191-18-045516 · doc4.xml · nonDerivative · entry 3 Hoffman Alan L · CIK 0001624527 · EVP, Global Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,285 F3 · kind: The reporting person received 9,840 shares of common stock upon the net exercise of 26,512 stock appreciation rights ("SARS"). The reporting person forfeited 6,991 shares of common stock underlying the SARS in payment of the exercise price and 9,681 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on August 2, 2018 of $57.74. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 20:16 UTC |
Hoffman Alan LEVP, Global Corporate Affairs
|
Exercise / conversionCommon Stock | 26,512 | $15.22 | $403,512.64 |
DisclosureSEC source: 0001209191-18-045516 · doc4.xml · nonDerivative · entry 2 Hoffman Alan L · CIK 0001624527 · EVP, Global Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The reporting person received 9,840 shares of common stock upon the net exercise of 26,512 stock appreciation rights ("SARS"). The reporting person forfeited 6,991 shares of common stock underlying the SARS in payment of the exercise price and 9,681 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on August 2, 2018 of $57.74. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 20:16 UTC |
Hoffman Alan LEVP, Global Corporate Affairs
|
SaleCommon Stock | 55,576 | $57.50 | $3,195,620.00 |
DisclosureSEC source: 0001209191-18-045516 · doc4.xml · nonDerivative · entry 1 Hoffman Alan L · CIK 0001624527 · EVP, Global Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,764 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2018. F2 · balance_after: On May 14, 2018, the common stock of Herbalife Nutrition Ltd. split 2-for-1, resulting in the reporting person's acquisition of 29,670 additional shares of common stock. Read SEC document |
| June 18, 2018 Filed Jun 18, 2018 23:46 UTC |
LEVY ROBERTEVP, The Americas
|
SaleCommon Stock | 9,316 | $54.00 | $503,064.00 |
DisclosureSEC source: 0001209191-18-038426 · doc4.xml · nonDerivative · entry 7 LEVY ROBERT · CIK 0001311283 · EVP, The Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 512,988 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2018. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 23:46 UTC |
LEVY ROBERTEVP, The Americas
|
Exercise / conversionStock Appreciation Rights · Derivative | 21,206 | $0.00 Strike: $15.22 | $0.00 |
DisclosureSEC source: 0001209191-18-038426 · doc4.xml · derivative · entry 9 LEVY ROBERT · CIK 0001311283 · EVP, The Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,206 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These SARS were previously reported as covering 10,603 shares at an exercise price of $30.44 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2018. F5 · derivative.underlying_shares: These SARS were previously reported as covering 10,603 shares at an exercise price of $30.44 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 23:46 UTC |
LEVY ROBERTEVP, The Americas
|
Exercise / conversionStock Appreciation Rights · Derivative | 10,008 | $0.00 Strike: $29.99 | $0.00 |
DisclosureSEC source: 0001209191-18-038426 · doc4.xml · derivative · entry 8 LEVY ROBERT · CIK 0001311283 · EVP, The Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,008 shares Expires 2024-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: These SARs were previously reported as covering 5,004 shares at an exercise price of $59.98 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2018. F4 · derivative.underlying_shares: These SARs were previously reported as covering 5,004 shares at an exercise price of $59.98 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 23:46 UTC |
LEVY ROBERTEVP, The Americas
|
Tax withholdingCommon Stock | 8,019 | $54.00 | $433,026.00 |
DisclosureSEC source: 0001209191-18-038426 · doc4.xml · nonDerivative · entry 6 LEVY ROBERT · CIK 0001311283 · EVP, The Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 522,304 F3 · kind: The reporting person received 7,210 shares of common stock upon the net exercise of 21,206 SARs. The reporting person forfeited 5,977 shares of common stock underlying such SARs in payment of the exercise price and 8,019 shares of common stock underlying such SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on June 14, 2018 of $54.00. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 23:46 UTC |
LEVY ROBERTEVP, The Americas
|
Disposition to issuerCommon Stock | 5,977 | $54.00 | $322,758.00 |
DisclosureSEC source: 0001209191-18-038426 · doc4.xml · nonDerivative · entry 5 LEVY ROBERT · CIK 0001311283 · EVP, The Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 530,323 F3 · kind: The reporting person received 7,210 shares of common stock upon the net exercise of 21,206 SARs. The reporting person forfeited 5,977 shares of common stock underlying such SARs in payment of the exercise price and 8,019 shares of common stock underlying such SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on June 14, 2018 of $54.00. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 23:46 UTC |
LEVY ROBERTEVP, The Americas
|
Exercise / conversionCommon Stock | 21,206 | $15.22 | $322,755.32 |
DisclosureSEC source: 0001209191-18-038426 · doc4.xml · nonDerivative · entry 4 LEVY ROBERT · CIK 0001311283 · EVP, The Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2018. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 23:46 UTC |
LEVY ROBERTEVP, The Americas
|
Tax withholdingCommon Stock | 2,343 | $54.00 | $126,522.00 |
DisclosureSEC source: 0001209191-18-038426 · doc4.xml · nonDerivative · entry 3 LEVY ROBERT · CIK 0001311283 · EVP, The Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515,094 F2 · kind: The reporting person received 2,106 shares of common stock upon the net exercise of 10,008 stock appreciation rights ("SARs"). The reporting person forfeited 5,559 shares of common stock underlying such SARs in payment of the exercise price and 2,343 shares of common stock underlying such SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on June 14, 2018 of $54.00. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 23:46 UTC |
LEVY ROBERTEVP, The Americas
|
Disposition to issuerCommon Stock | 5,559 | $54.00 | $300,186.00 |
DisclosureSEC source: 0001209191-18-038426 · doc4.xml · nonDerivative · entry 2 LEVY ROBERT · CIK 0001311283 · EVP, The Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 517,437 F2 · kind: The reporting person received 2,106 shares of common stock upon the net exercise of 10,008 stock appreciation rights ("SARs"). The reporting person forfeited 5,559 shares of common stock underlying such SARs in payment of the exercise price and 2,343 shares of common stock underlying such SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on June 14, 2018 of $54.00. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 23:46 UTC |
LEVY ROBERTEVP, The Americas
|
Exercise / conversionCommon Stock | 10,008 | $29.99 | $300,139.92 |
DisclosureSEC source: 0001209191-18-038426 · doc4.xml · nonDerivative · entry 1 LEVY ROBERT · CIK 0001311283 · EVP, The Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 522,996 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2018. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 20:17 UTC |
JOHNSON MICHAELDirector · Executive Chairman
|
Exercise / conversionStock Appreciation Rights · Derivative | 815,660 | $0.00 Strike: $15.22 | $0.00 |
DisclosureSEC source: 0001209191-18-036928 · doc4.xml · derivative · entry 10 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 815,660 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.underlying_shares: These SARS were previously reported as covering 407,830 shares at an exercise price of $30.44 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 20:17 UTC |
JOHNSON MICHAELDirector · Executive Chairman
|
Exercise / conversionStock Appreciation Rights · Derivative | 384,910 | $0.00 Strike: $29.99 | $0.00 |
DisclosureSEC source: 0001209191-18-036928 · doc4.xml · derivative · entry 9 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 384,910 shares Expires 2024-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.underlying_shares: These SARS were previously reported as covering 192,455 shares at an exercise price of $59.98 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 20:17 UTC |
JOHNSON MICHAELDirector · Executive Chairman
|
Tax withholdingCommon Stock | 304,064 | $52.13 | $15,850,856.32 |
DisclosureSEC source: 0001209191-18-036928 · doc4.xml · nonDerivative · entry 6 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,479,158 F3 · kind: The reporting person received 273,452 shares of common stock upon the net exercise of 815,660 SARS. The reporting person forfeited 238,144 shares of common stock underlying such SARS in payment of the exercise price and 304,064 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on June 7, 2018 of $52.13. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 20:17 UTC |
JOHNSON MICHAELDirector · Executive Chairman
|
Disposition to issuerCommon Stock | 238,144 | $52.13 | $12,414,446.72 |
DisclosureSEC source: 0001209191-18-036928 · doc4.xml · nonDerivative · entry 5 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,783,222 F3 · kind: The reporting person received 273,452 shares of common stock upon the net exercise of 815,660 SARS. The reporting person forfeited 238,144 shares of common stock underlying such SARS in payment of the exercise price and 304,064 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on June 7, 2018 of $52.13. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 20:17 UTC |
JOHNSON MICHAELDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 815,660 | $15.22 | $12,414,345.20 |
DisclosureSEC source: 0001209191-18-036928 · doc4.xml · nonDerivative · entry 4 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,021,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.